ENGG 390 Reports (MEM Students)
Degree Program
M.E.M
Year of Graduation
2023
Sponsor
Torreya Partners, New York City, New York
Faculty Advisor
Dave Tabor
Document Type
Report
Publication Date
Summer 9-2-2022
Abstract
For the past summer, I served as a summer analyst at an investment bank in New York, specializing in healthcare coverage. Accordingly, I primarily engaged with healthcare corporations, helping them execute transactions such as equity and bond offering, mergers and acquisitions, private placement, spin-off, divestiture, restructuring, and more. One of the projects I was staffed on was a licensing transaction for which I needed to conduct a valuation of its clinical-stage pharmaceutical assets to provide an accurate intrinsic value. To do so, I incorporate the random forest model and PrOCTOR method developed by the Department of Public Health into the traditional risk-adjusted net present value model so that my client could better understand the value of the drug in the pipeline.
Level of Access
Restricted: Campus/Dartmouth Community Only Access
Dartmouth Digital Commons Citation
Yan, Han, "Intrinsic Value Valuation of Diabetes Pharmaceutical Assets" (2022). ENGG 390 Reports (MEM Students). 211.
https://digitalcommons.dartmouth.edu/engs390/211
Restricted
Available to Dartmouth community via local IP address.
